Intrinsic Value of S&P & Nasdaq Contact Us

Accuray Incorporated ARAY NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
41/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.00
+399.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Accuray Incorporated (ARAY) has a negative trailing P/E of -1.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 3.3 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -81.91%, forward earnings yield 29.94%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+399.5%).
  • Forward P/E 3.3 — analysts expect a return to profitability with estimated EPS of $0.12 for FY2028.
  • Trailing Earnings Yield -81.91% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 29.94% as earnings recover.
  • Analyst consensus target $2.00 (+399.5% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 41/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
41/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
29/100
→ Income
GROWTH
30/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ARAY

Valuation Multiples
P/E (TTM)-1.2
Forward P/E3.3
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.81
P/S Ratio0.10
EV/EBITDA-99.1
Per Share Data
EPS (TTM)$-0.30
Forward EPS (Est.)$0.12
Book Value / Share$0.45
Revenue / Share$3.64
FCF / Share$-0.05
Yields & Fair Value
Earnings Yield-81.91%
Forward Earnings Yield29.94%
Dividend Yield0.00%
Analyst Target$2.00 (+399.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -16.4 0.44 7.00 1.05 -
2017 -13.2 -1.06 8.42 1.02 -
2018 -14.6 0.66 7.16 0.86 -
2019 -20.8 0.65 6.86 0.82 -
2020 47.7 -0.39 2.87 0.48 -
2021 -65.9 0.25 6.04 1.05 -
2022 -33.8 2.21 3.39 0.42 -
2023 -39.6 -0.58 6.84 0.82 -
2024 -11.1 -0.17 3.84 0.39 -
2025 -88.5 0.98 1.73 0.31 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.32 $398.8M $-25.5M -6.4%
2017 $-0.36 $383.41M $-29.58M -7.7%
2018 $-0.28 $404.9M $-23.9M -5.9%
2019 $-0.19 $418.79M $-16.43M -3.9%
2020 $0.04 $382.93M $3.83M 1%
2021 $-0.07 $396.29M $-6.31M -1.6%
2022 $-0.06 $429.91M $-5.35M -1.2%
2023 $-0.10 $447.61M $-9.28M -2.1%
2024 $-0.16 $446.55M $-15.55M -3.5%
2025 $-0.02 $458.51M $-1.59M -0.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.32 $-0.32 – $-0.32 $443.2M $442.12M – $444.28M 1
2027 $-0.01 $-0.01 – $-0.01 $463.5M $462.37M – $464.63M 1
2028 $0.12 $0.12 – $0.12 $482.8M $481.62M – $483.98M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message